News >

Neoadjuvant Chemo Linked to Above 95% OS in Squamous Cell Cervical Cancer

Jason Harris
Published: Monday, Oct 23, 2017

A review of patients with locally advanced bulky squamous cell carcinoma (SCC) of the uterine cervix who underwent chemoradiation followed by surgery with pelvic lymphadenectomy showed that the technique was associated with a 5-year overall survival (OS) of 95.7%.

There were no treatment-related deaths in the study, though 1 patient died of recurrence and 2 died of unknown reasons after more than 100 months. Seven events in 4 patients led to the development of postoperative fistula formation requiring a rescue surgery. Three patients (13.0%) developed distant metastases, 1 of whom showed local recurrence later.
Nakao Y, Hashiguchi M, Nishiyama S, et al. Preoperative chemoradiotherapy in locally advanced bulky squamous cell carcinoma of the uterine cervix [published online August 3, 2017]. Int J Gynecol Cancer. doi: 10.1097/IGC.0000000000001094.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Show Me the Data™: Leveraging Evidence to Optimize Applications of PARP Inhibitor Strategies in Ovarian CancerJun 29, 20191.5
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x